Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 8
Submit an article Journal homepage
27
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Secondary B-cell acute lymphoblastic leukemia following Wilms' tumor: Clinical and in vitro chemosensitivity studies

H Ariffin Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia; Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, MalaysiaCorrespondence[email protected]
,
T Muthukkumaran Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia; Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
,
J Stanslas Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia; Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
,
AR Sabariah Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia; Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
,
N Veerasekaran Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia; Department of Haematology, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
&
HP Lin Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia; Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Pages 1233-1237 | Received 15 Feb 2005, Published online: 03 Aug 2009

References

  • Blatt J, Olshan A, Gula MJ, Dickman PS, Zaianek B. Second malignancies in very long-term survivors of childhood cancer. Am J Med 1992;93:57–60.
  • Moss TJ, Staruss LC, Das L, Feig SA. Secondary leukaemia following successful treatment of Wilms' tumor. Am J Pediatr Hematol Oncol 1989;11:158–161.
  • Shearer P, Kapoor G, Beckwith JB, Takashima J, Breslow N, Green DM. Secondary acute myeloid leukemia in patients previously treated for childhood renal tumours: a report from the National Wilms Tumour Study Group. J Pediatr Hematol Oncol 2001;23:109–111.
  • Mollgard L, Tidefelt U, Sundman-Engberg B, Lofgrn C, Paul C. In vitro chemosensitivity testing in acute non-lymphocytic leukemia using the bioluminescence ATP assay. Leuk Res 2000;24:445–452.
  • Wang Y, Ashkenazi YJ, Bacharach U. In vitro chemosensitivity testing of hematological cancers: immunohistochemical detec-tion of ornithine decarboxylase. Anticancer Drugs 1999;10:797–805.
  • Lepri E, Liberati M, Menconi E, Santucci A, Piselli F, Barzi A. In vitro chemosensitivity testing in acute leukemia: results of a retrospective study. Anticancer Res 1990;10:1735–1738.
  • Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. The incidence of secondary leukemias. Haematologica 1999;84:937–945.
  • Ivy SP, Olshefski RS, Taylor BJ, Patel KM, Reaman GH. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a Children's Cancer Group study. Blood 1996;88:309–318.
  • Vilpo J, Koski T, Vilpo L. Calcium antagonists potentiate P-glycoprotein independent anticancer drugs in chronic lym-phocytic leukemia cells in vitro. Haematologica 2000;85:806–813.
  • Taylor HJH, Graven P, Plowman PN. Secondary acute myeloid leukaemia (AML) (expressing 11q23 mutation) occurring 11 months after chemotherapy/radiotherapy for paediatric non-Hodgkin's lymphoma (NHL). Chin Oncol 2000;12: 112–114.
  • Hunger SP, Sklar J, Link MP. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Chin Oncol 1992;10:156–163.
  • Pagano L, Alessandro P, Mele L, Leone G. Clinical and epidemiological features of acute lymphoblastic leukaemia following a previous malignancy. L,euk Lymphoma 2000;39:465–475.
  • Schrappe M, Arico M, Harbott J, Biondi A, Zimmermann M, Conter V, et al. Philadelphia chromosome-positive (Ph +) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998;92:2730–2734.
  • Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, et al. Prednisone response is the strongest predictor of treatment outcome in infants with acute lymphoblastic leukemia. Blood 1999;94:1209–1217.
  • Zwaan CM, Kaspers GJL, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wunsche R, et al. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood 2000;96:2879–2886.
  • Friedman HS, Kerby T, Calvert H. Temozolomide and treatment of malignant glioma. Chin Cancer Res 2000;6:2585–2597.
  • den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, et al. Relationship between major vault protein/lung resistance protein, multidrug resistance-asso-ciated protein, p-glycoprotein expression and drug resistance in childhood leukemia. Blood 1998;91:2092–2098.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.